Is diphenhydramine appropriate for use as a sleep aid in a hospitalized adult patient, and what dosing and safety precautions should be followed?

Diphenhydramine Should NOT Be Used for Sleep in Hospitalized Patients

The American Academy of Sleep Medicine explicitly recommends AGAINST using diphenhydramine for sleep onset or sleep maintenance insomnia in adults 1. This is a formal guideline recommendation that should guide your practice in the hospital setting.

Why Diphenhydramine Fails as a Sleep Aid

The evidence against diphenhydramine is compelling:

• Minimal efficacy: Sleep latency improved by only 8 minutes compared to placebo (with confidence intervals that include NO benefit), and total sleep time increased by just 12 minutes (again, confidence intervals include potential harm) 1
• No quality improvement: Patients report NO improvement in subjective sleep quality compared to placebo 1
• Rapid tolerance: Complete tolerance to sedative effects develops within 3-4 days of regular use, making it ineffective for ongoing sleep issues 2

Specific Safety Concerns in Hospitalized Patients

Hospitalized patients face additional risks with diphenhydramine:

• Anticholinergic effects: Particularly dangerous in older adults, causing confusion, delirium, urinary retention, constipation, and falls
• Contraindications per FDA labeling: Avoid in patients with chronic bronchitis, glaucoma, or enlarged prostate 3
• Drug interactions: Potentiates sedatives, tranquilizers, and alcohol—common in hospitalized patients 3
• Daytime impairment: Marked drowsiness persists into the next day, affecting mobility and rehabilitation 3

What to Use Instead

The American College of Physicians recommends a hierarchical approach 4:

First-line (always): Address environmental factors in the hospital—noise reduction, light control, minimizing nighttime vital signs and procedures

Second-line: If pharmacotherapy is necessary for SHORT-TERM use:

• Zolpidem 10 mg: Improves sleep latency by 29 minutes and reduces wake after sleep onset by 25 minutes 1
• Eszopiclone 2-3 mg: Increases total sleep time by 28-57 minutes with moderate-to-large quality improvements 1
• Doxepin 3-6 mg: Particularly effective for sleep maintenance (reduces wake after sleep onset by 22 minutes) 1
• Suvorexant 10-20 mg: Reduces wake after sleep onset by 16-28 minutes 1

Critical Caveats

• Duration matters: FDA approves hypnotics for only 4-5 weeks; observational data link long-term use to dementia, falls, and fractures 4
• Older adults: Use lower doses than studied; FDA specifically warns about increased risks in this population 4
• Not for chronic insomnia: If sleep issues persist beyond hospitalization, cognitive behavioral therapy for insomnia (CBT-I) is the only evidence-based long-term solution 4

Common Pitfall to Avoid

Despite diphenhydramine being readily available and seemingly "safe" as an OTC medication, its use in hospitalized patients represents outdated practice. The 2017 AASM guidelines are unequivocal in their recommendation against its use 1. Recent expert opinions even suggest diphenhydramine should be removed from widespread availability due to its problematic risk-benefit ratio 5.

Bottom line: Choose an FDA-approved hypnotic for short-term use if environmental modifications fail, but never reach for diphenhydramine as a sleep aid in hospitalized patients.